Human Neural Progenitor Cells(Cedars-Sinai Medical Center)

N/A

Report date: 2022/12/30 14:54:01

Base Information

Drug NameHuman Neural Progenitor Cells(Cedars-Sinai Medical Center)
Drug Alias NameCNS10-NPC
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCedars-Sinai Medical Center
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A